InMode Ltd. (INMD)
18.21
-0.21 (-1.14%)
At close: Mar 26, 2025, 3:59 PM
18.37
0.84%
After-hours: Mar 26, 2025, 06:14 PM EDT
-1.14% (1D)
Bid | 18.1 |
Market Cap | 1.27B |
Revenue (ttm) | 382.1M |
Net Income (ttm) | 175.44M |
EPS (ttm) | 2.25 |
PE Ratio (ttm) | 8.1 |
Forward PE | 8.83 |
Analyst | Hold |
Ask | 19.25 |
Volume | 1,181,743 |
Avg. Volume (20D) | 1,005,771 |
Open | 18.54 |
Previous Close | 18.42 |
Day's Range | 18.12 - 18.89 |
52-Week Range | 14.87 - 21.92 |
Beta | 2.08 |
About INMD
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin ...
Industry Medical - Devices
Sector Healthcare
IPO Date Aug 8, 2019
Employees 599
Stock Exchange NASDAQ
Ticker Symbol INMD
Website https://www.inmodemd.com
Analyst Forecast
According to 5 analyst ratings, the average rating for INMD stock is "Hold." The 12-month stock price forecast is $22, which is an increase of 20.78% from the latest price.
Stock ForecastsNext Earnings Release
InMode Ltd. is scheduled to release its earnings on May 1, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-7.99%
InMode shares are trading lower after the company ...
Unlock content with
Pro Subscription
6 months ago
+8.83%
InMode shares are trading higher after the company announced it approved a share repurchase program.